FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q77639628> ?p ?o ?g. }

• Q77639628 description "2002 nî lūn-bûn" @default.
• Q77639628 description "2002 թվականին հրատարակված գիտական հոդված" @default.
• Q77639628 description "2002年の論文" @default.
• Q77639628 description "2002年学术文章" @default.
• Q77639628 description "2002年学术文章" @default.
• Q77639628 description "2002年学术文章" @default.
• Q77639628 description "2002年学术文章" @default.
• Q77639628 description "2002年学术文章" @default.
• Q77639628 description "2002年学术文章" @default.
• Q77639628 description "2002年學術文章" @default.
• Q77639628 description "2002年學術文章" @default.
• Q77639628 description "2002年學術文章" @default.
• Q77639628 description "2002年學術文章" @default.
• Q77639628 description "2002年學術文章" @default.
• Q77639628 description "2002년 논문" @default.
• Q77639628 description "article científic" @default.
• Q77639628 description "article scientific" @default.
• Q77639628 description "article scientifique" @default.
• Q77639628 description "articol științific" @default.
• Q77639628 description "articolo scientifico" @default.
• Q77639628 description "artigo científico" @default.
• Q77639628 description "artigo científico" @default.
• Q77639628 description "artigo científico" @default.
• Q77639628 description "artikel ilmiah" @default.
• Q77639628 description "artikull shkencor" @default.
• Q77639628 description "artikulong pang-agham" @default.
• Q77639628 description "artykuł naukowy" @default.
• Q77639628 description "artículo científico publicado en 2002" @default.
• Q77639628 description "artículu científicu" @default.
• Q77639628 description "bilimsel makale" @default.
• Q77639628 description "bài báo khoa học" @default.
• Q77639628 description "im Februar 2002 veröffentlichter wissenschaftlicher Artikel" @default.
• Q77639628 description "naučni članak" @default.
• Q77639628 description "scienca artikolo" @default.
• Q77639628 description "scientific article published in February 2002" @default.
• Q77639628 description "scientific article published in February 2002" @default.
• Q77639628 description "scientific article published on 01 February 2002" @default.
• Q77639628 description "teaduslik artikkel" @default.
• Q77639628 description "tieteellinen artikkeli" @default.
• Q77639628 description "tudományos cikk" @default.
• Q77639628 description "vedecký článok" @default.
• Q77639628 description "vetenskaplig artikel" @default.
• Q77639628 description "videnskabelig artikel udgivet februar 2002" @default.
• Q77639628 description "vitenskapelig artikkel" @default.
• Q77639628 description "vitskapeleg artikkel" @default.
• Q77639628 description "vědecký článek" @default.
• Q77639628 description "wetenschappelijk artikel" @default.
• Q77639628 description "επιστημονικό άρθρο" @default.
• Q77639628 description "мақолаи илмӣ" @default.
• Q77639628 description "наукова стаття, опублікована в лютому 2002" @default.
• Q77639628 description "научна статия" @default.
• Q77639628 description "научная статья" @default.
• Q77639628 description "научни чланак" @default.
• Q77639628 description "научни чланак" @default.
• Q77639628 description "מאמר מדעי" @default.
• Q77639628 description "مقالة علمية نشرت في فبراير 2002" @default.
• Q77639628 description "ফেব্রুয়ারি ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q77639628 description "บทความทางวิทยาศาสตร์" @default.
• Q77639628 description "სამეცნიერო სტატია" @default.
• Q77639628 name "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 name "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 name "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 type Item @default.
• Q77639628 label "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 label "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 label "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 prefLabel "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 prefLabel "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 prefLabel "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 P1433 Q77639628-FAFE2706-EB72-47AF-B80C-4B6772D54685 @default.
• Q77639628 P1476 Q77639628-A09D3172-03A3-4783-8BEB-36E347EC0168 @default.
• Q77639628 P2093 Q77639628-402395F6-E597-4327-802D-50AC8F0310AD @default.
• Q77639628 P2093 Q77639628-6E984A67-D74A-4928-8C2D-F97AE53CC200 @default.
• Q77639628 P2093 Q77639628-C709E1BF-F8D5-46B7-9382-0BB4EF3D13C3 @default.
• Q77639628 P304 Q77639628-C0BF51C8-0067-494D-B9D2-9469F8A3220E @default.
• Q77639628 P31 Q77639628-90F33159-5D53-485E-9990-5AB018BCDC14 @default.
• Q77639628 P356 Q77639628-8AC9C699-075F-4D4F-96CD-54A3769978B0 @default.
• Q77639628 P407 Q77639628-A1B71923-815F-4B22-BE07-A1E875BAFF60 @default.
• Q77639628 P433 Q77639628-FEAFC4A1-C35D-4886-96D7-1CCFBF8E4C3F @default.
• Q77639628 P478 Q77639628-681120F5-E118-43F4-857F-C9196AD79595 @default.
• Q77639628 P577 Q77639628-EFB7A4C5-0E2F-49FA-814F-2580D0C5CC09 @default.
• Q77639628 P698 Q77639628-BAD55935-875D-480F-B8B9-F12524200DF5 @default.
• Q77639628 P921 Q77639628-1A3F8D57-A13F-450A-BE1E-4A98A35BBE28 @default.
• Q77639628 P356 JCO.2002.20.4.1000 @default.
• Q77639628 P698 11844823 @default.
• Q77639628 P1433 Q400292 @default.
• Q77639628 P1476 "Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination" @default.
• Q77639628 P2093 "Manfred Schmitt" @default.
• Q77639628 P2093 "Nadia Harbeck" @default.
• Q77639628 P2093 "Ronald E Kates" @default.
• Q77639628 P304 "1000-1007" @default.
• Q77639628 P31 Q13442814 @default.
• Q77639628 P356 "10.1200/JCO.2002.20.4.1000" @default.
• Q77639628 P407 Q1860 @default.
• Q77639628 P433 "4" @default.
• Q77639628 P478 "20" @default.
• Q77639628 P577 "2002-02-01T00:00:00Z" @default.
• Q77639628 P698 "11844823" @default.
• Q77639628 P921 Q107129060 @default.